At 8.6% CAGR, the Asia Pacific Organ Preservation Solutions Market is projected to be worth US$ 76.94 Million by 2028, says The Business Market Insights

According to the Business Market Insights’ research, the Asia Pacific organ preservation solutions market was valued at US$ 51.04 Million in 2023 and is expected to reach US$ 76.94 Million by 2028, registering a CAGR of 8.6% from 2023 to 2028. Rising need for organ transplantation and increasing prevalence of chronic diseases leading to kidney failure are the critical factors attributed to the Asia Pacific organ preservation solutions market expansion.

CVDs are heart and blood vessel disorders, which include cerebrovascular diseases, coronary heart disease, rheumatic heart disease, and other diseases. Tobacco use, unhealthy diet, and physical inactivity, which increase the risk of heart attacks and strokes, are some of the major causes of death and difficulty. CVDs are the world's leading cause of death, affecting more than any other disease.

Cardiovascular diseases are becoming more and more prevalent around the world. Cardiovascular diseases are the world's leading cause of death. Most CVD deaths are followed by a stroke and heart failure due to coronary heart disease (CHD). It is also stated that around 31% of all deaths are caused by cardiovascular diseases worldwide. According to organdonor.gov, the heart is the third-largest vital organ transplantation performed after kidney and liver. Besides, new technologies for a heart transplant will offer lucrative opportunities for the organ preservation solutions market. Technological innovation also has been playing a critical role in increasing the widespread uptake of organ transplantation. For instance, the Transmedics Organ Care System (OCS) Heart or "Heart in a Box," enables transplant doctors to travel to much farther locations in search of transplant hearts by acting as a miniature intensive care unit that maintains the heart's viability.

The increasing need for a heart transplant, owing to the increasing prevalence of cardiovascular diseases, is expected to boost the market growth during the prediction period.

On the contrary, expensive organ transplant surgeries hurdles the growth of Asia Pacific organ preservation solutions market.

Based on type, the Asia Pacific organ preservation solutions market is segmented into University of Wisconsin solution, custodiol HTK, perfadex, hypothermosol, and others. The University of Wisconsin solution segment held 39.9% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 20.37 Million. It is projected to garner US$ 30.74 Million by 2028 to expand at 8.6 % CAGR during 2023–2028.

Based on application, the Asia Pacific organ preservation solutions market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held 45.8% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 23.38 Million. It is projected to garner US$ 35.65 Million by 2028 to expand at 8.8% CAGR during 2023–2028.  

Based on organ type, the Asia Pacific organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held 59.3% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 30.27 Million. It is projected to garner US$ 46.13 Million by 2028 to expand at 8.8% CAGR during 2023–2028.

Based on end user, the Asia Pacific organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics, The organ transplant centers segment held 54.5% share of Asia Pacific organ preservation solutions market in 2023, amassing US$ 27.83 Million. It is projected to garner US$ 42.48 Million by 2028 to expand at 8.8% CAGR during 2023–2028.

Based on country, the Asia Pacific organ preservation solutions market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that Japan captured 31.3% share of Asia Pacific organ preservation solutions market in 2023. It was assessed at US$ 16.03 Million in 2023 and is likely to hit US$ 24.58 Million by 2028, exhibiting a CAGR of 8.9% during the forecast period.      

Key players operating in the Asia Pacific organ preservation solutions market are Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Shanghai Genext Pharmaceutical Technology; TransMedics; and XVIVO Perfusion among others.   

• In June 2019, TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com